Structural and Inhibition Analysis Reveals the Mechanism of Selectivity of a Series of Aggrecanase Inhibitors (Q27646508)

2

0 references

Karl J Mathis

3

0 references

Mark E Schnute

4

0 references

Scott S Woodard

5

0 references

Grace Munie

6

0 references

Jennifer M Williams

7

0 references

Nicole Caspers

8

0 references

Arthur J Wittwer

9

0 references

Anne-Marie Malfait

10

0 references

Huey-Sheng Shieh

Journal of Biological Chemistry

11

0 references

language of work or name

English

0 references

publication date

4 September 2009

0 references

published in

0 references

volume

284

0 references

issue

36

0 references

page(s)

24185-91

0 references

cites work

High resolution crystal structure of the catalytic domain of ADAMTS-5 (aggrecanase-2)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2782012

Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2782012

Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2782012

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2782012

Will the real aggrecanase(s) step up: evaluating the criteria that define aggrecanase activity in osteoarthritis.

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2782012

The futility of current approaches to chondroprotection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2782012

Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2782012

Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2782012

Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2782012

Aggrecan protects cartilage collagen from proteolytic cleavage

2 June 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109.029116

Potent P1' biphenylmethyl substituted aggrecanase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109.029116

Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109.029116

A two step purification of recombinant human interleukin-1 beta expressed in E. coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109.029116

ADAMTS-4 (aggrecanase-1): N-terminal activation mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109.029116

Production of human matrix metalloproteinase 3 (stromelysin) in Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109.029116

Substrate-dependent inhibition kinetics of an active site-directed inhibitor of ADAMTS-4 (Aggrecanase 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109.029116

High-throughput screening of enzyme inhibitors: simultaneous determination of tight-binding inhibition constants and enzyme concentration

21 January 2018

1 reference

12 December 2020

Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips

1 reference

12 December 2020

A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases

1 reference

12 December 2020

The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement

1 reference

12 December 2020

The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation

1 reference

12 December 2020